You are here: Industry Insights > COVID-19

News List

ApiJect Systems Approved for $590 Million Loan contractpharma
November 25, 2020
Supports building a U.S.-based facility with surge capacity to produce up to 3 billion single-dose prefilled plastic injectors per year.
Samsung Biologics Breaks Ground on 'Super Plant' contractpharma
November 25, 2020
When completed, the CDMO says it will be the world's largest bio-manufacturing facility.
HiFiBiO, Pharmsynthez and IBCh sign Covid-19 antibody development deal pharmaceutical-technology
November 25, 2020
HiFiBiO Therapeutics has entered into a partnership with Pharmsynthez and Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry RAS (IBCh) to develop and commercialise its SARS-CoV-2 neutralising antibody, HFB30132A, for Covid-19 treatment.
Merck agrees to buy biopharma firm OncoImmune for $425m pharmaceutical-technology
November 25, 2020
Merck (MSD) has signed a definitive agreement to acquire all outstanding shares of clinical-stage biopharmaceutical firm OncoImmune through a subsidiary, for an upfront payment of $425m in cash.
Favipiravir shows significant improvement in time to clinical cure for mild to moderate COVID-19 expresspharma
November 25, 2020
These findings were observed in Phase 3 clinical trial conducted by Glenmark Pharmaceuticals and have been published by the International Journal of Infectious Diseases.
Governments should work as a team for smooth, sustained COVID-19 vaccination drive: PM Modi expresspharma
November 25, 2020
The PM said that any vaccine against coronavirus that is administered to citizens will meet all necessary scientific criteria.
Tony Blair Institute and Oracle Launch Africa Vaccine Management in the Cloud prnasia
November 24, 2020
The Tony Blair Institute (TBI) and Oracle have brought cloud technology to Africa to manage public health programs. Initially, Ghana, Rwanda, and Sierra Leone will use the new Oracle Health Management System to create electronic health records for ...
Koru Lifescience preparing to send drug compounds to preclinical and clinical trials based on their study for Covid-19 prnasia
November 24, 2020
Koru Lifescience, drug discovery, and advanced formulation research laboratory in Auckland, New Zealand, has identified several known drug compounds of value in their study for a treatment of Covid-19.
Arizona BioTech Company Successfully Completes Pre-Clinical Testing for Vaccine Alternative to Prevent COVID-19 Infection, Ready for Human Trials prnewswire
November 24, 2020
Sotira, the Phoenix based biotech company, is pleased to announce the successful completion of the second phase of pre-clinical testing for its COVID-19 therapeutic and vaccine-alternative, KEPTIDE? COVID, confirming that this cutting-edge molecular ...
AstraZeneca starts COVID-19 prevention trial for immunocompromised patients europeanpharmaceuticalreview
November 24, 2020
The trial will evaluate if the long-acting monoclonal antibody cocktail, AZD7442, can prevent COVID-19 in patients who cannot be vaccinated.